Skip to main content

Covista Inc.

corporate_fare Company Profile

Covista Inc.

CVSA·NYSE·Trade & Services·CIK 0000730464

Covista Inc. is America's largest healthcare educator, serving 100,000 students and supported by an alumni network of 400,000 across five accredited institutions: Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. Covista delivers education to its students at multiple campuses and online, offering educational programs across nursing, medicine, veterinary medicine, and the social and behavioral sciences. The company's strategy focuses on expanding access to healthcare education and addressing the U.S. healthcare workforce shortage. Covista operates through three reportable segments. The Chamberlain segment includes the operations of Chamberlain University, which offers degree and certificate programs in the nursing and health professions postsecondary education industry. Chamberlain was founded in 1889 as Deaconess College of Nursing and acquired by Covista in 2005. The Walden segment includes the operations of Walden University, offering degree and certificate programs in areas such as nursing, education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice. The Medical and Veterinary segment includes the operations of American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine, which collectively offer degree and certificate programs in the medical and veterinary postsecondary education industry. Covista was incorporated in Delaware in August 1987, with executive offices located at 233 South Wacker Drive, Chicago, Illinois, 60606.

Covista Inc. (NYSE:CVSA) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 6 items for CVSA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-06, rated 8/10. Across its 6 most recent items scored 7 or higher, the top rating is 8/10, with 5 rated 8 or above. Recent SEC coverage for CVSA spans 10-K, 8-K, 10-Q.

Recent high-impact activity:

  • Covista FY2026: Revenue Climbs 9.3% to $1.95B, Diluted EPS Hits $7.04, Walden Enrollment Surges 13.2%
  • Covista Surpasses FY2026 Targets and Sets FY2027 Outlook with 8–11% Adjusted EPS Growth
  • Covista Beats FY2026 Guidance, Revenue Hits $1.95B; Initiates FY2027 Outlook
  • Covista Reports Strong Revenue and Adjusted Earnings Growth, Proactive Debt Refinancing, and Continued Share Buybacks
  • Strong Q3 Performance Leads Covista to Boost Full-Year Outlook

Financial Snapshot

Fiscal year ended June 30, 2025
Revenue
$1.79B
Net Income
$237.06M
Diluted EPS
$6.18
Op. Cash Flow
$337.9M
Free Cash Flow
$287.57M
Gross Profit
$1.02B
Operating Income
$341.54M
Cash & Equivalents
$199.6M
Total Debt
$552.67M
Debt / Equity
0.39×
Net Margin
13.3%
Shares Outstanding
35.95M sh
Source: 10-K · filed 2025-08-07 · accession 0001558370-25-010780
Browse all tickers starting with C →
$125.09
52-week range · as of 2026-08-06 $86.97 – $156.26
Market cap
$4.26B
Volume
198.6K (0.6× avg)
3-mo avg 346.3K
Live data · 2026-09-13 20:43 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CVSA - Latest Insights

CVSA
Aug 06, 2026, 4:21 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $126.50
Real-time Price: $125.09 info
Change: -$1.41 (-1%) info
Market Cap: $4.258B info
CVSA
Aug 06, 2026, 4:19 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $126.50
Real-time Price: $125.09 info
Change: -$1.41 (-1%) info
Market Cap: $4.258B info
CVSA
Aug 06, 2026, 4:05 PM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $125.32
Real-time Price: $125.09 info
Change: -$0.230 (-0.18%) info
Market Cap: $4.258B info
CVSA
May 07, 2026, 4:18 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $119.51
Real-time Price: $125.09 info
Change: +$5.58 (+5%) info
Market Cap: $4.258B info
CVSA
May 07, 2026, 4:13 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $119.51
Real-time Price: $125.09 info
Change: +$5.58 (+5%) info
Market Cap: $4.258B info
CVSA
Apr 09, 2026, 8:01 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $118.00
Real-time Price: $125.09 info
Change: +$7.09 (+6%) info
Market Cap: $4.258B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets